Mental Health Daily

Genetics & Depression: How Polygenic Risk Scores Predict Mood Over Long-Term (2024 Study)

by GLOOM

A recent study examined how our genetic makeup influences our temperament traits, particularly in relation to depression. By analyzing the polygenic risk for depression (PRS) and its correlation with various temperament traits over time, this research provides significant insights into the complex interplay between genetics and mood. Highlights: High PRS Linked to Increased Persistence: Individuals …

Genetics of Tobacco Use Disorder (TUD) & Nicotine Addiction (2024 Study)

by GLOOM

Tobacco use is a complex behavior influenced by both environmental factors and genetic predispositions. A recent study leveraging the UCLA ATLAS biobank explored the genetic underpinnings of Tobacco Use Disorder (TUD) and its systemic health effects using a Polygenic Score (PGS). Highlights: Genetic Underpinnings of Tobacco Use: The study used a European ancestry-derived PGS to …

Genetic Risk for Low Vitamin D Linked to Lower Social Motivation in First-Episode Psychosis (2024 Study)

by GLOOM

Recent research reveals a notable association between vitamin D levels and the severity of negative symptoms in individuals with first-episode psychosis (FEP). A new study explored the genetic predisposition towards lower vitamin D levels and its impact on symptom severity in schizophrenia and related disorders. Highlights: Vitamin D & Psychosis Connection: Lower levels of vitamin …

Minocycline for PTSD: Inhibition of Fear Memory Retention via MMP-9 (2024 Study)

by GLOOM

Recent research has uncovered the potential of minocycline, a tetracycline antibiotic, in modifying fear memory retention. A new study conducted by Yanfang Xia and colleagues, published in Translational Psychiatry, highlights how minocycline could play a role in treating anxiety and stress-related disorders. Highlights: Study Basis: The study was based on Pavlovian fear conditioning as a …

Genetics & Age-Related Cognitive Decline: Insights from TOMORROW Trial (2024 Study)

by GLOOM

In a study utilizing data from the TOMMORROW trial, researchers have embarked on a novel exploration of genetic associations with cognitive change in older individuals. Employing a genome-wide association study (GWAS) approach, they’ve identified specific genetic variants linked to cognitive dynamics, providing new insights into the genetic underpinnings of cognitive change with aging. Highlights: Novel …

Combo of Neuroimaging, Transcriptome, Epigenetics to Understand Gray Matter Abnormalities in Major Depression (2024 Study)

by GLOOM

Major depressive disorder (MDD) affects millions worldwide, yet its underlying causes remain largely enigmatic. A new study integrated neuroimaging, transcriptomic, and epigenetic data to better understand the genetic underpinnings of MDD. This comprehensive approach revealed a complex interplay between brain structure, gene expression, and DNA methylation, offering new insights into this debilitating condition. Highlights: Integrative …

Probiotics & Synbiotics for the Metabolic Side Effects of Psychiatric Medications: Are They Effective? (2024 Review)

by GLOOM

Patients with severe mental illnesses (SMI), such as schizophrenia and chronic depression, often face the challenge of managing weight gain and metabolic complications, side effects commonly associated with antipsychotics and antidepressants. These medications are known to induce increased appetite and weight gain, leading to long-term metabolic syndromes. Recent studies have evaluated into the role of …